文献速递肺外科心外重症与机械循环支持

体外膜氧合作为肺移植桥接的结局分析

Outcomes of Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplantation.
PubMed 文献 · Ann Thorac Surg · 2019-02-18

该研究回顾性分析了2009年4月至2018年7月哥伦比亚大学医学中心121例以ECMO作为肺移植桥接的成人患者,70例(59%)成功桥接至肺移植。简化急性生理评分II、非计划气管插管、肾脏替代治疗和脑血管意外是不成功桥接的独立预测因素,而行走是成功桥接的唯一独立预测因素(OR 7.579,95%CI 2.158-26.615,p=0.002)。出院存活64例(91%),1年生存率88%,3年生存率83%;倾向性匹配显示BTT与非BTT肺移植受者生存无显著差异(log-rank p=0.53)。

要点

  • ECMO作为肺移植桥接可使59%的终末期肺病患者成功过渡至移植。
  • 行走是成功桥接的唯一独立预测因素(OR 7.579),应重视康复活动。
  • BTT患者移植后生存与非BTT受者相当,但需严格方案和经验团队。

核心结论

  • ECMO可成功将终末期肺病患者桥接至肺移植,在经验丰富的团队严格遵循方案和患者选择的情况下,BTT患者结局与未接受移植前支持的患者相当。

研究设计与样本

  • 回顾性分析2009年4月至2018年7月哥伦比亚大学医学中心121例接受ECMO作为BTT的成人患者的电子病历数据。

主要发现

  • 121例患者中70例(59%)成功桥接至肺移植。
  • 简化急性生理评分II、非计划气管插管、肾脏替代治疗和脑血管意外是不成功BTT的独立预测因素。
  • 行走是成功BTT的唯一独立预测因素(OR 7.579,95%CI 2.158-26.615,p=0.002)。
  • 出院存活64例(91%),1年生存率88%,3年生存率83%。
  • 倾向性匹配显示BTT与非BTT肺移植受者生存无显著差异(log-rank p=0.53),尽管肺分配评分中位数差异显著(92.2 [IQR 89.0-94.2] vs 49.6 [IQR 40.6-72.3],p<0.01)。

关键数值与推荐

  • 成功桥接至肺移植的比例为59%(70/121)。
  • 行走预测成功BTT的OR为7.579(95%CI 2.158-26.615,p=0.002)。
  • 出院存活者1年生存率88%,3年生存率83%。
  • BTT与非BTT倾向匹配后生存log-rank p=0.53。
  • 肺分配评分中位数BTT组92.2(IQR 89.0-94.2) vs 非BTT组49.6(IQR 40.6-72.3),p<0.01。

临床怎么用

  • 对终末期肺病等待肺移植的患者,可考虑ECMO作为桥接手段,但需由经验丰富的团队实施并遵循严格方案。
  • 应重视患者活动能力(行走)作为成功桥接的可干预预测因素。
  • 需警惕简化急性生理评分II高、非计划气管插管、肾脏替代治疗和脑血管意外等不利因素。

局限性

  • 回顾性单中心研究,样本量有限(121例),结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Extracorporeal membrane oxygenation (ECMO) as a bridge to lung transplantation (BTT) has become a critical component of caring for patients with end-stage lung disease. This study examined outcomes of patients who received ECMO as a BTT. METHODS: Statistical analysis was performed on data gathered retrospectively from the electronic medical records of adult patients who received ECMO as BTT at Columbia University Medical Center from April 2009 through July 2018. RESULTS: A total of 121 adult patients were placed on ECMO as BTT, and 70 patients (59%) were successfully bridged to lung transplantation. Simplified Acute Physiology Score II, unplanned endotracheal intubation, renal replacement therapy, and cerebrovascular accident were identified as independent predictors of unsuccessful BTT. Ambulation was the only independent predictor of successful BTT (odds ratio, 7.579; 95% confidence interval, 2.158 to 26.615; p = 0.002). Among the 64 patients (91%) who survived to hospital discharge, survival was 88% at 1 year and 83% at 3 years. Propensity matching between BTT and non-BTT lung transplant recipients did not show a significant difference in survival (log-rank = 0.53) despite significant differences in the lung allocation score (median, 92.2 [interquartile range, 89.0 to 94.2] vs 49.6 [interquartile range, 40.6 to 72.3], p < 0.01). CONCLUSIONS: ECMO can be used successfully to bridge patients with end-stage lung disease to lung transplantation. When implemented by an experienced team with adherence to stringent protocols and patient selection, outcomes in BTT patients were comparable to patients who did not receive pretransplant support.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Tipograf Y, Salna M, Minko E, et al. Outcomes of Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplantation. Ann Thorac Surg. 2019. PMID: 30790550. doi:10.1016/j.athoracsur.2019.01.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。